Not a good buy right now: price is in a clear downtrend (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram below 0 and expanding negatively).
The stock is only ~1–2% above key support (S2 ~2.865) after a -3.62% regular-session drop; this is a weak tape for an “impatient” entry.
Options positioning (OI put/call 1.67) leans bearish/defensive and there’s essentially no volume to validate a bullish turn.
Fundamentals are not supporting a quick sentiment reversal (Q3 2025 revenue down YoY, losses widened), and there are no near-term news catalysts.
Net: Avoid buying now; if you already hold, the setup argues for exiting rather than adding.
Momentum: MACD histogram -0.00143 below zero and negatively expanding → downside momentum is strengthening, not stabilizing.
RSI: RSI_6 = 24.40 (oversold/washed-out). This can spark short bounces, but by itself is not a trend reversal signal.
Levels: Pivot 3.106 is overhead (needs reclaim to improve tape). Immediate support S1 2.957 (already below in post-market at 2.9); next support S2 2.865. Resistance levels: R1 3.255, R2 3.347.
Price context: Post-market 2.9 sits near support, but the breakdown below S1 increases odds of a support test at ~2.865.
Sentiment (Open Interest): Put/call OI ratio 1.67 (puts > calls) suggests bearish positioning or heavier hedging than bullish speculation.
Activity: Today’s options volume is 0 (no meaningful flow confirmation).
Volatility: 30D IV 182.38 vs historical vol 73.91 → options are pricing very large moves; this is often seen around uncertainty (earnings on 2026-02-12 pre-market).
Positioning note: Today vs open interest avg 30D = 246.15 indicates OI is elevated versus its typical baseline, but without volume today it’s not signaling a fresh bullish turn.
Technical Summary
Sell
7
Buy
3
Positive Catalysts
increases the probability of a short-term technical bounce.
Neutral/Negative Catalysts
in post-market increases risk of a quick test of S2 (~2.
or lower.
with no volume confirming bullish demand.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: 77.65M, down -10.60% YoY (top-line contraction).
Profitability: Net income -14.94M, down -18.10% YoY (losses widened).
EPS: -1.01, down -20.47% YoY (earnings deterioration).
Margin: Gross margin 12.22%, up strongly YoY (a bright spot), but not yet translating into bottom-line improvement.
Overall: Financial trend is still negative (shrinking revenue + deeper losses), which typically caps near-term upside without a clear catalyst.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the dataset.
Wall Street pro/con view (based strictly on available data):
Cons: Revenue declining, losses widening, and technical trend is decisively bearish—these typically outweigh the margin improvement for near-term buyers.
Wall Street analysts forecast GGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GGR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast GGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GGR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.